Chemoinformaics analysis of 2,7-Dihydroxy-3-methoxy-9H-xanthen-9-one
| Molecular Weight | 691.267 | nRot | 44 |
| Heavy Atom Molecular Weight | 596.515 | nRig | 27 |
| Exact Molecular Weight | 690.725 | nRing | 0 |
| Solubility: LogS | -3.069 | nHRing | 0 |
| Solubility: LogP | 3.933 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 143 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 49 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 94 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 47 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 142.773 |
| nHD | 0 | BPOL | 96.9055 |
| QED | 0.606 |
| Synth | 3.907 |
| Natural Product Likeliness | 0.957 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.972 |
| Pgp-sub | 0.672 |
| HIA | 0.004 |
| CACO-2 | -5.15 |
| MDCK | 0.0000126 |
| BBB | 0.203 |
| PPB | 0.806403 |
| VDSS | 1.56 |
| FU | 0.0746687 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.945 |
| CYP2c19-inh | 0.044 |
| CYP2c19-sub | 0.962 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.308 |
| CYP2d6-inh | 0.35 |
| CYP2d6-sub | 0.953 |
| CYP3a4-inh | 0.149 |
| CYP3a4-sub | 0.937 |
| CL | 6.562 |
| T12 | 0.405 |
| hERG | 0.944 |
| Ames | 0.054 |
| ROA | 0.31 |
| SkinSen | 0.137 |
| Carcinogencity | 0.016 |
| EI | 0.006 |
| Respiratory | 0.763 |
| NR-Aromatase | 0.328 |
| Antiviral | Yes |
| Prediction | 0.529414 |